Zhejiang Tianyu Pharmaceutical Co., Ltd.

XSEC:300702 Stock Report

Market Cap: CN¥5.6b

Zhejiang Tianyu Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Zhejiang Tianyu Pharmaceutical has a total shareholder equity of CN¥3.5B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 47.6%. Its total assets and total liabilities are CN¥6.4B and CN¥2.9B respectively. Zhejiang Tianyu Pharmaceutical's EBIT is CN¥92.8M making its interest coverage ratio 2.4. It has cash and short-term investments of CN¥495.2M.

Key information

47.6%

Debt to equity ratio

CN¥1.68b

Debt

Interest coverage ratio2.4x
CashCN¥495.20m
EquityCN¥3.53b
Total liabilitiesCN¥2.90b
Total assetsCN¥6.43b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300702's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥2.6B).

Long Term Liabilities: 300702's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥286.4M).


Debt to Equity History and Analysis

Debt Level: 300702's net debt to equity ratio (33.6%) is considered satisfactory.

Reducing Debt: 300702's debt to equity ratio has increased from 9% to 47.6% over the past 5 years.

Debt Coverage: 300702's debt is well covered by operating cash flow (25.3%).

Interest Coverage: 300702's interest payments on its debt are not well covered by EBIT (2.4x coverage).


Balance Sheet


Discover healthy companies